Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Abbott Laboratories turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B | $34.61B | $31.90B | $30.58B | $27.39B | $20.85B |
| Revenue Growth? | +5.7% | +4.6% | -8.1% | +1.3% | +24.5% | +8.5% | +4.3% | +11.6% | +31.3% | 0.0% |
| Cost of Revenue? | $19.72B | $20.63B | $20.07B | $21.33B | $19.86B | $17.23B | $15.21B | $14.76B | $14.32B | $9.61B |
| Gross Profit? | $24.61B | $21.32B | $20.04B | $22.32B | $23.21B | $17.38B | $16.69B | $15.82B | $13.07B | $11.24B |
| Gross Margin? | +55.5% | +50.8% | +50.0% | +51.1% | +53.9% | +50.2% | +52.3% | +51.7% | +47.7% | +53.9% |
| Operating Expenses? | $16.59B | $14.47B | $13.60B | $13.96B | $14.01B | $12.09B | $12.10B | $11.98B | $11.09B | $8.00B |
| Operating Income? | $8.05B | $6.83B | $6.43B | $8.36B | $9.20B | $5.29B | $4.59B | $3.84B | $1.97B | $3.25B |
| EBITDA? | $11.55B | $10.83B | $10.61B | $11.89B | $12.16B | $9.00B | $7.91B | $6.88B | $6.13B | $3.07B |
| Income Before Tax | $8.47B | $7.01B | $6.66B | $8.31B | $8.21B | $4.97B | $4.08B | $2.87B | $2.23B | $1.41B |
| Income Tax Expense | $1.94B | -$6.39B | $941.00M | $1.37B | $1.14B | $497.00M | $390.00M | $539.00M | $1.88B | $350.00M |
| Net Income? | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B | $4.50B | $3.69B | $2.37B | $477.00M | $1.40B |
| EPS? | $3.74 | $7.67 | $3.30 | $3.94 | $3.97 | $2.52 | $2.07 | $1.35 | $0.27 | $0.95 |
| Diluted EPS? | $3.72 | $7.64 | $3.27 | $3.91 | $3.94 | $2.50 | $2.06 | $1.34 | $0.27 | $0.94 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality